K&L GATES, LLP

Lobbying for BORYUNG CORPORATION · South Korean healthcare and pharmaceutical company.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 19, 2026

Income

$10,000.00

What the client paid this registrant for the period.

Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Aerospace

Issues related to pharmaceutical and life sciences in space.

Pharmacy

Issues related to pharmaceutical and life sciences in space.

Science/Technology

Issues related to pharmaceutical and life sciences in space.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.